Literature DB >> 16305821

The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.

M J C van der Sangen1, L V van de Poll-Franse, R M H Roumen, H J T Rutten, J W W Coebergh, G Vreugdenhil, A C Voogd.   

Abstract

AIMS: The increasing use of breast-conserving therapy (BCT) and the rising incidence and improved prognosis of early breast are causing a substantial increase in the absolute number of patients with a late local recurrence following BCT. This study examined the characteristics and the prognosis of patients with a local recurrence occurring more than 5 years after BCT.
METHODS: In the period 1982-1997, 3280 patients with invasive breast cancer underwent breast-conserving therapy in one of the eight community hospitals in the South-eastern part of The Netherlands. Of these patients, 98 developed a local recurrence in the breast more than 5 years after BCT.
RESULTS: Eighty-five of the 98 recurrences were invasive, 12 were purely in situ and for one patient this information was not available. The 5 years distant recurrence-free survival rate of 85 patients with a late invasive local recurrence was 68% (95% confidence interval [CI], 56-80) and significantly better than the rate of 41% (95% CI, 33-48) in an existing cohort of 173 patients with invasive recurrence within 5 years after BCT (p=0.007). Local excision of the recurrence was followed by a significantly lower local control rate than salvage mastectomy (50 vs 89%; p=0.004).
CONCLUSION: The prognosis of patients with a local recurrence more than 5 years after BCT is significantly better than of patients with local recurrence within 5 years after BCT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305821     DOI: 10.1016/j.ejso.2005.10.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  16 in total

1.  Local relapse after breast-conserving surgery and radiotherapy: effects on survival parameters.

Authors:  Josef Hammer; Christine Track; Dietmar H Seewald; Kurt J Spiegl; Johannes Feichtinger; Andreas L Petzer; Werner Langsteger; Sabine Pöstlberger; Elisabeth Bräutigam
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

2.  Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.

Authors:  Willemina R R Geurts-Giele; Victorien M T van Verschuer; Carolien H M van Deurzen; Paul J van Diest; Rute M S M Pedrosa; J Margriet Collée; Linetta B Koppert; Caroline Seynaeve; Winand N M Dinjens
Journal:  Mod Pathol       Date:  2016-09-09       Impact factor: 7.842

3.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.

Authors:  Stewart J Anderson; Irene Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Jong-Hyeon Jeong; Charles E Geyer; D Lawrence Wickerham; Joseph P Costantino; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

4.  Options for early breast cancer follow-up in primary and secondary care - a systematic review.

Authors:  Frances Taggart; Peter Donnelly; Janet Dunn
Journal:  BMC Cancer       Date:  2012-06-13       Impact factor: 4.430

5.  Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.

Authors:  Annemieke Witteveen; Annemiek B G Kwast; Gabe S Sonke; Maarten J IJzerman; Sabine Siesling
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

Review 6.  Current approaches and challenges in early detection of breast cancer recurrence.

Authors:  Erika J Schneble; Lindsey J Graham; Matthew P Shupe; Frederick L Flynt; Kevin P Banks; Aaron D Kirkpatrick; Aviram Nissan; Leonard Henry; Alexander Stojadinovic; Nathan M Shumway; Itzhak Avital; George E Peoples; Robert F Setlik
Journal:  J Cancer       Date:  2014-03-16       Impact factor: 4.207

7.  Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.

Authors:  Marie Gosset; Anne-Sophie Hamy; Peter Mallon; Myriam Delomenie; Delphine Mouttet; Jean-Yves Pierga; Marick Lae; Alain Fourquet; Roman Rouzier; Fabien Reyal; Jean-Guillaume Feron
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

8.  Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival.

Authors:  S Ciatto; N Houssami; F Martinelli; R Bonardi; F H Cafferty; S W Duffy
Journal:  Br J Cancer       Date:  2008-07-15       Impact factor: 7.640

Review 9.  Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature.

Authors:  D A Montgomery; K Krupa; T G Cooke
Journal:  Br J Cancer       Date:  2007-11-13       Impact factor: 7.640

10.  Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery.

Authors:  Jun Hee Lee; Se Kyung Lee; Sung Min Park; Jae Min Ryu; Hyun June Paik; Ha Woo Yi; Soo Youn Bae; Jeong Eon Lee; Seok Won Kim; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.